Coadministration of cruzipain and GM-CSF DNAs, a new immunotherapeutic vaccine against Trypanosoma cruzi infection.
about
Methodological approach to the ex vivo expansion and detection of T. cruzi-specific T cells from chronic Chagas disease patients.Trans-sialidase-based vaccine candidate protects against Trypanosoma cruzi infection, not only inducing an effector immune response but also affecting cells with regulatory/suppressor phenotype.Trypanosoma cruzi 80 kDa prolyl oligopeptidase (Tc80) as a novel immunogen for Chagas disease vaccine.
P2860
Coadministration of cruzipain and GM-CSF DNAs, a new immunotherapeutic vaccine against Trypanosoma cruzi infection.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 27 August 2015
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Coadministration of cruzipain ...... t Trypanosoma cruzi infection.
@en
Coadministration of cruzipain ...... t Trypanosoma cruzi infection.
@nl
type
label
Coadministration of cruzipain ...... t Trypanosoma cruzi infection.
@en
Coadministration of cruzipain ...... t Trypanosoma cruzi infection.
@nl
prefLabel
Coadministration of cruzipain ...... t Trypanosoma cruzi infection.
@en
Coadministration of cruzipain ...... t Trypanosoma cruzi infection.
@nl
P2093
P2860
P1476
Coadministration of cruzipain ...... t Trypanosoma cruzi infection.
@en
P2093
Andrés Sánchez Alberti
Augusto E Bivona
Fernanda M Frank
Mauricio C De Marzi
Natacha Cerny
Silvia I Cazorla
P2860
P304
P356
10.1080/21645515.2015.1078044
P577
2015-08-27T00:00:00Z